KP Tissue Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	8.5	2.43	-4.94	-10.25	1.24	Upgrade
Loss (Gain) From Sale of Investments	0.66	0.5	0.13	4.46	5	Upgrade
Loss (Gain) on Equity Investments	-9.17	-2.99	0.7	8.09	-6.13	Upgrade
Other Operating Activities	-	0.65	3.82	-2.22	-0.35	Upgrade
Change in Accounts Receivable	-	-	-	-	0.02	Upgrade
Change in Accounts Payable	-	-0.6	0.29	-0.08	0.21	Upgrade
Investment in Securities	-	-	-	6.62	5.56	Upgrade
Other Investing Activities	6.96	6.97	6.98	-	-	Upgrade
Investing Cash Flow	6.96	6.97	6.98	6.62	5.56	Upgrade
Common Dividends Paid	-6.96	-6.97	-6.98	-6.62	-5.56	Upgrade
Financing Cash Flow	-6.96	-6.97	-6.98	-6.62	-5.56	Upgrade
Cash Income Tax Paid	-	-0.6	0.29	-0.08	2.28	Upgrade
Change in Working Capital	-	-0.6	0.29	-0.08	0.23	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.